129 related articles for article (PubMed ID: 38819821)
1. Optimal Oral Iron Therapy for Iron Deficiency Anemia Among US Veterans.
Patel N; Silvey SG; Arora P; Feldman GM
JAMA Netw Open; 2024 May; 7(5):e2414305. PubMed ID: 38819821
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial.
Powers JM; Buchanan GR; Adix L; Zhang S; Gao A; McCavit TL
JAMA; 2017 Jun; 317(22):2297-2304. PubMed ID: 28609534
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial.
Li N; Zhao G; Wu W; Zhang M; Liu W; Chen Q; Wang X
JAMA Netw Open; 2020 Nov; 3(11):e2023644. PubMed ID: 33136134
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
Awan AA; Walther CP; Richardson PA; Shah M; Winkelmayer WC; Navaneethan SD
Nephrol Dial Transplant; 2021 Jan; 36(1):129-136. PubMed ID: 31641775
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency.
Cesarano D; Borrelli S; Campilongo G; D'Ambra A; Papadia F; Garofalo C; De Marco A; Marzano F; Ruotolo C; Gesualdo L; Cirillo P; Minutolo R
Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732502
[TBL] [Abstract][Full Text] [Related]
7. Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease.
Pergola PE; Belo D; Crawford P; Moustafa M; Luo W; Goldfarb-Rumyantzev A; Farag YMK
Am J Nephrol; 2021; 52(7):572-581. PubMed ID: 34293738
[TBL] [Abstract][Full Text] [Related]
8. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
Onken JE; Bregman DB; Harrington RA; Morris D; Buerkert J; Hamerski D; Iftikhar H; Mangoo-Karim R; Martin ER; Martinez CO; Newman GE; Qunibi WY; Ross DL; Singh B; Smith MT; Butcher A; Koch TA; Goodnough LT
Nephrol Dial Transplant; 2014 Apr; 29(4):833-42. PubMed ID: 23963731
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia.
Kaundal R; Bhatia P; Jain A; Jain A; Nampoothiri RV; Mishra K; Jandial A; Goni D; Sandal R; Jindal N; Meshram A; Sharma R; Khaire N; Singh C; Khadwal A; Prakash G; Das R; Varma N; Varma S; Malhotra P; Lad DP
Ann Hematol; 2020 Jan; 99(1):57-63. PubMed ID: 31811360
[TBL] [Abstract][Full Text] [Related]
10. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial.
Womack R; Berru F; Panwar B; Gutiérrez OM
Clin J Am Soc Nephrol; 2020 Sep; 15(9):1251-1258. PubMed ID: 32694162
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
13. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
Ziedan A; Bhandari S
Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
[TBL] [Abstract][Full Text] [Related]
14. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
[TBL] [Abstract][Full Text] [Related]
15. Alternate day versus daily oral iron for treatment of iron deficiency anemia: a randomized controlled trial.
Pasupathy E; Kandasamy R; Thomas K; Basheer A
Sci Rep; 2023 Feb; 13(1):1818. PubMed ID: 36725875
[TBL] [Abstract][Full Text] [Related]
16. A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.
Akizawa T; Yamaguchi Y; Otsuka T; Reusch M
Nephron; 2020; 144(8):372-382. PubMed ID: 32580188
[TBL] [Abstract][Full Text] [Related]
17. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Meier Y; Larroque S; Roger SD;
BMC Nephrol; 2017 Jan; 18(1):24. PubMed ID: 28095881
[TBL] [Abstract][Full Text] [Related]
18. Role of Anemia in Dementia Risk Among Veterans With Incident CKD.
Koyama AK; Nee R; Yu W; Choudhury D; Heng F; Cheung AK; Norris KC; Cho ME; Yan G
Am J Kidney Dis; 2023 Dec; 82(6):706-714. PubMed ID: 37516301
[TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).
Reinisch W; Staun M; Tandon RK; Altorjay I; Thillainayagam AV; Gratzer C; Nijhawan S; Thomsen LL
Am J Gastroenterol; 2013 Dec; 108(12):1877-88. PubMed ID: 24145678
[TBL] [Abstract][Full Text] [Related]
20. Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria.
Raji YR; Ajayi SO; Akingbola TS; Adebiyi OA; Adedapo KS; Salako BL
Niger Postgrad Med J; 2018; 25(4):197-203. PubMed ID: 30588939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
